Tag: AI Drug Discovery
AI-designed lung drug tilts aging clocks younger in trial data
Insilico says rentosertib, its AI-built IPF candidate, shifted six proteomic aging clocks toward younger profiles in a 12-week trial analysis.
Insilico’s compact MMAI models outdo dedicated drug discovery tools
Insilico's MMAI Gym specialist models post winning scores across drug discovery benchmarks.
China clears Mprosevir, its first AI-assisted Class 1 drug
NMPA clears Westlake's Mprosevir, China's first AI-assisted Class 1 drug.
Superluminal scores $60M to carry AI-designed obesity pill to clinic
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.
Owkin’s AI scientist lands at Boehringer Ingelheim labs
Boehringer Ingelheim licenses Owkin's K Pro AI scientist and multimodal oncology and immunology data.
Astromech scores $20M to predict biology’s next moves
The Colossal spin-off reaches a $3.8B valuation for AI that forecasts evolutionary change.
Blinded contest exposes uneven AI antibody design results
A blinded 29-team contest shows AI antibody tools can win in narrow tasks but fail at affinity prediction.
AI-discovered drugs still need a human name on the patent
US patent law still demands a human inventor even when AI did the creative work.